Division of Hematology/Oncology

Faculty

faculty photo

Kenneth M. Algazy, MD

Physician, Penn Presbyterian Medical Center
Physician, Hospital of the University of Pennsylvania
Section Chief, Hematology/Oncology, Philadelphia VAMC
Department: Medicine

Contact information
Perelman Center 2nd Floor West
and Phila. VAMC 8A120
Philadelphia, PA 19104
Office: 215-615-5810
Fax: 215-615-5888
Education:
BS
Villanova University, 1965.
MD
Temple University School of Medicine, 1969.
Post-Graduate Training
Intern in Medicine, Abington Memorial Hospital, Abington, PA, 1969-1970.
Resident in Medicine, Strong Memorial Hospital, Rochester, NY, 1970-1972.
Fellowship, Hematology, Johns Hopkins University Hospital, Baltimore, MD, 1972-1974.
Certifications
National Board of Medical Examiners, 1970.
American Board of Internal Medicine, 1972.
American Board of Internal Medicine (Hematology), 1974.
American Board of Internal Medicine (Medical Oncology), 1979.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

clinical trials

Description of Clinical Expertise

Lung cancer

Description of Other Expertise

general oncology and hematology

Selected Publications

Chapters: Idiopathic Thrombocytopenic Purpura, Polycythemia Vera, Thrombocytosis, Cold Induced Hemolysis. NORD Guide to Rare Diseases. Lippincott Williams and Wilkins, Philadelphia, Pennsylvania, 2003.

Algazy KM: EBV Associated Severe Thrombocytopenia. Resident & Staff Physician Mar 2003.

Campling, B.G., Hwang, W-T., Zhang, J., Thompson, S., Vachani, A., Rosen, I.M., K.M.Algazy: The University of Pennsylvania School of Medicine And the Philadelphia VA Medical Center, Philadelphia , Pa: Population Based Study of Lung Cancer in Penna.: Comparison of VA and Civilian Populations. Cancer May 2003.

Stevenson, J., Nho, C.W., Schick, J., Johnson, S.W., Algazy, K., Miller, D., & P.J.Odwyer: Phase II Clinical/pharmacodynamic Trial of the Proteosome Inhibitor PS341 In Advanced Non-Small Cell Lung Cancer. American Society of Clinical Oncology Annual Meeting May 2003.

Bilenker, J.H., Rosen, M.A., Gallagher, M.A., Stevenson, J.P., Flaherty, K.T., Algazy, K.M., Sun, W., Schnall, M., & P.J.Odwyer: Phase 1b Trial of Combretastatin in Combination with Carboplatin in Patients with Advanced cancer. American Society of Clinical Oncology Annual Meeting May 2003.

Campbell A., Campling B., Algazy KM., El-Diery, W: Bedside-to-Bench Report: Clinical and molecular features of small cell carcinoma of the lung. Cancer Biology and Therapy 1/2: 105-112, March/April 2002.

Algazy KM: Spinner’s Hematuria (Letter to the Editor). New England Journal of Medicine 346(21): 1676, 2002.

Rosenthal DI., Yom SS., Liu L., Machtay M., Algazy KM., Weber RS., Weinstein GS., Chalian AA., Miller LK., Rockwell K., Tonda M., Schnipper E., Hershock D: A Phase I study of SPI-77 (Stealth Liposomal Cisplatin) concurrent with radiation therapy for locally advanced head and neck cancer. Investigational New Drugs 20: 343-349, 2002.

Stevenson, JP,Sun, W., Gallagher, M., Johnson, R., Vaugn, D. Schuchter, L., Algazy, K.: Phase I Trial of Cryptophysin Analogue Ly355703. Clinical Cancer Research Page: 2524-2529, Aug 2002.

Sun, W.,Stevenson, J.P., Gallo, J.M., Redlinger, M., Haller, D., Algazy, K., Giantonio, B., Alila, H., Odwyer, P.J: Phase I and Pharmacokinetic Trial of a ProapoptoticSulindac Analogue CP-461 in Patients with Advanced Cancer Clinical Cancer Research 8(10): 3100-3104, Oct 2002.

back to top
Last updated: 01/18/2014
The Trustees of the University of Pennsylvania
 

Clinical Briefings Blog Spot

Penn MD Forum title with Penn Medicine Shield and Twitter